Last reviewed · How we verify

NCT02731833

Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

Completed Phase 4 Results posted Last updated 17 May 2017
What this trial tests

Phase 4 trial testing stannous fluoride in Dentin Sensitivity in 229 participants. Completed in 20 May 2016.

Timeline
1 April 2016
Primary endpoint
1 May 2016
20 May 2016

Quick facts

Lead sponsorGlaxoSmithKline
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment229
Start date1 April 2016
Primary completion1 May 2016
Estimated completion20 May 2016
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

GlaxoSmithKline — full company profile →

Who can join

Adults 18 to 65, any sex, with Dentin Sensitivity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change From Baseline in Schiff Sensitivity Score on Day 3 Primary · Baseline to Day 3

The examiner assessed the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant does not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score was indicative of an improvement in sensiti

GroupValue95% CI
Stannous Fluoride-0.40± 0.485
Sodium Monofluorophosphate0.00± 0.257
Change From Baseline in Tactile Threshold on Day 3 Secondary · Baseline to Day 3

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gives two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.

GroupValue95% CI
Stannous Fluoride3.69± 4.941
Sodium Monofluorophosphate0.09± 2.521
Change From Baseline in Schiff Sensitivity Score Post First Treatment by Direct Application Secondary · Baseline to 60 seconds post first treatment

The examiner assessed the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant does not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score was indicative of an improvement in sensiti

GroupValue95% CI
Stannous Fluoride-0.17± 0.340
Sodium Monofluorophosphate-0.02± 0.269
Change From Baseline in Tactile Threshold Post First Treatment by Direct Application Secondary · Baseline to 60 seconds post first treatment

The examiner assessed the response to tactile sensitivity using a Yeaple probe which allowed application of a known force to the dentin surface, starting at 10g and rising in increments of 10g until the tactile threshold or maximum force was reached. The tactile threshold for each tooth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gives two consecutive 'yes' responses was recorded as the tactile threshold. The higher the tactile threshold, the less sensitive the tooth.

GroupValue95% CI
Stannous Fluoride1.71± 3.268
Sodium Monofluorophosphate0.18± 2.328

Sponsor's own description

This single centre, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Randomised clinical studies investigating immediate and short-term efficacy of an occluding toothpaste in providing dentine hypersensitivity relief.
    Creeth J, Gallob J, Sufi F, Qaqish J, et al · · 2019 · cited 8× · PMID 31164116 · DOI 10.1186/s12903-019-0781-x

Verify or expand the search:

Other trials of stannous fluoride

Trials testing the same drug.

Other recruiting trials for Dentin Sensitivity

Currently open trials in the same condition.

Other GlaxoSmithKline trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02731833.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing